-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Oruka Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
- Oruka Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$53.1M, a 3238% decline year-over-year.
- Oruka Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$88.1M, a 1108% decline year-over-year.
- Oruka Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$88.1M, a 1108% decline from 2023.
- Oruka Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$7.3M, a 31.1% increase from 2022.
- Oruka Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$10.6M, a 45.2% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)